Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults

Cephalalgia

Volumn 28, Issue 5, 2008, Pages 484-495

  Silberstein, S ^a   Tfelt Hansen, P ^b   Dodick, D W ^c   Limmroth, V ^d   Lipton, R B ^e   Pascual, J ^f   Wang, S J ^g  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c MAYO CLINIC   (United States)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^g NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Chronic migraine; Clinical trials; Headache; Medication overuse headache; Prophylactic treatment

Indexed keywords

DISEASE CLASSIFICATION; DISEASE DURATION; DRUG INDUCED HEADACHE; HEADACHE; HUMAN; INTERNATIONAL COOPERATION; MEDICAL SOCIETY; METHODOLOGY; MIGRAINE; PATIENT SELECTION; PRACTICE GUIDELINE; PROPHYLAXIS; QUALITY CONTROL; REVIEW; TRANSFORMED MIGRAINE;

ADULT; ANALGESICS; CHRONIC DISEASE; CONTROLLED CLINICAL TRIALS AS TOPIC; HUMANS; MIGRAINE DISORDERS; PHYSICIAN'S PRACTICE PATTERNS;

EID: 41849101483     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2008.01555.x     Document Type: Review

References (43)

1. Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB. Transformed migraine and medication overuse in a tertiary headache centre - clinical characteristics and treatment outcomes. Cephalalgia 2004 24 : 483 90.
2. D'Amico D, Grazzi L, Usai S, Rigamonti A, Curone M, Bussone G. Disability pattern in chronic migraine with medication overuse: a comparison with migraine without aura. Headache 2005 45 : 553 60.
3. Headache Classification Committee. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006 26 : 742 6.
4. Silberstein SD, Olesen J, Bousser MG, Diener HC, Dodick D, First M et al. International Headache Society. The international classification of headache disorders, 2nd edn (ICHD-II) - revision of criteria for 8.2 Medication-overuse headache. Cephalalgia 2005 25 : 460 5.
5. International Headache Society Committee on Clinical Trials in Migraine. Guidelines for controlled trials of drugs in migraine, 1st edn. Cephalalgia 1991 11 : 1 12.
6. International Headache Society Clinical Trial Subcommittee. Guidelines for controlled trials of drugs in migraine, 2nd edn. Cephalalgia 2000 20 : 765 86.
7. International Headache Society Committee on Clinical Trials (Schoenen J, Chairman). Guidelines for trials of drug treatments in tension-type headache, 1st edn. Cephalalgia 1995 15 : 165 79.
8. International Headache Society Committee on Clinical Trials in Cluster Headache (Solomon S, chairman). Guidelines for controlled trials in cluster headache, 1st edn. Cephalalgia 1995 15 : 452 61.
9. Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ. Topmati-MIG-201 (TOP-CHROME) Study Group. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 2007 27 : 814 23.
10. Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N et al. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache 2007 47 : 170 80.
11. Good CS. The Principles and Practice of Clinical Trials. Edinburgh, London, New York : Churchill Livingstone, 1976.
12. Pocock SJ. Clinical Trials. A Practical Approach. Chichester, New York, Brisbane, Toronto, Singapore : John Wiley & Sons, 1983.
13. Meinert CL. Clinical Trials - Design, Conduct, and Analysis. New York : Oxford University Press, 1986.
14. Spilker B. Guide to clinical trials. New York : Raven Press, 1991.
15. Olesen J, Krabbe A, Tfelt-Hansen P. Methodological aspects of prophylactic drug trials in migraine. Cephalalgia 1981 1 : 127 41.
16. Tfelt-Hansen P, Olesen J. Methodological aspects of drug trials in migraine. Neuroepidemiology 1985 4 : 204 26.
17. Clifford Rose F, editor. Methodological problems in migraine trials. Neuroepidemiology 1987 6 : 163 238.
18. Olesen J, Tfelt-Hansen P. Methodology of Migraine Trials. In : Orgogozo JM, Capildeo R, editors. Methods in Clinical Trials in Neurology. Vascular and Degenerative Brain Disease. London : MacMillan Press Ltd, 1988 : 85 109.
19. Olesen J, Tfelt-Hansen P. Headache. In : Porter RJ, Schoenberg BS, editors. Controlled Clinical Trials in Neurological Disease. Boston, Dortrecht, London : Kluwer Academic Publishers, 1990 : 185 201.
20. Olesen J, Tfelt-Hansen P, editors. 6th international headache research seminar. Headache treatment. Trial Methodology and New Drugs. New York : Lippincott-Raven, 1997.
21. Lipton RB. Methodologic issues in acute migraine clinical trials. Neurology 2000 55 (9 Suppl. 2 S3 7.
22. Ethics Subcommittee of the International Headache Society. Ethical issues in headache research and management. Cephalalgia 1998 18 : 505 29.
23. Sørensen KV. Valproate: a new drug in migraine prophylaxis. Acta Neurol Scand 1988 78 : 346 8.
24. Hockaday JM. Problems in childhood migraine. Neuroepidemiology 1987 6 : 234 8.
25. Mulleners WM, Whitmarsh TE, Steiner TJ. Noncompliance may render migraine prophylaxis useless, but once-daily regimens are better. Cephalalgia 1998 18 : 52 6.
26. Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population - a prevalence study. J Clin Epidemiol 1991 44 : 1147 57.
27. Russell MB, Rasmussen BK, Thorvaldsen P, Olesen J. Prevalence and sex-ratio of the subtypes of migraine. Int J Epidemiol 1995 24 : 612 18.
28. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 1992 267 : 64 9.
29. Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003 106 : 81 9.
30. Wang SJ, Fuh JL, Lu SR, Liu CY, Hsu LC, Wang PN, Liu HC. Chronic daily headache in Chinese elderly: prevalence, risk factors, and biannual follow-up. Neurology 2000 54 : 314 19.
31. Castillo J, Munoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache 1999 39 : 190 6.
32. Lipton RB, Stewart WF. Migraine headaches: epidemiology and comorbidity. Clin Neurosci 1998 5 : 2 9.
33. Pascual J, Leira RL, Láinez JM. Combined therapy for migraine prevention? Clinical experience with a beta-blocker plus sodium valproate in 52 resistant migraine patients. Cephalalgia 2003 23 : 961 2.
34. Pascual J, Rivas MT, Leira R. Testing the combination beta-blocker plus topiramate in refractory migraine. Acta Neurol Scand 2007 115 : 81 3.
35. Goadsby PJ, Schoenen J, Ferrari MD, Silberstein SD, Dodick D. Towards a definition of intractable headache for use in clinical practice and trials. Cephalalgia 2006 26 : 1168 70.
36. Migraine-Nimodipine European Study Group (MINES). European multicenter trial of nimodipine in the prophylaxis of classic migraine (migraine with aura). Headache 1989 29 : 639 42.
37. Lewis JA. Migraine trials: crossover or parallel group. Neuroepidemiology 1987 6 : 198 208.
38. Solomon GD, Dahlöf C. Impact of headache on the individual sufferer. In : Olesen J, Tfelt-Hansen P, Welch KMA, editors. The Headaches, 2nd edn. Philadelphia : Lippincott Williams & Wilkins, 2000 : 25 31.
39. Diener HC, Agosti R, Allais G, Bergmans P, Bussone G, Davies B et al. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2007 6 : 1054 62.
40. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd edn. Cephalalgia 2004 24 (Suppl. 1 9 160.
41. Murray CJ. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ 1994 72 : 429 45.
42. EEC Notes for Guidance. Good clinical practice for trials on medicinal products in the European community. Pharmacol Toxicol 1990 67 : 361 72.
43. Dixon JR Jr. The international conference on harmonization good clinical practice guideline. Qual Assur 1998 6 : 65 74.